Pfizer Comprehensive Income 2010-2024 | PFE

Pfizer comprehensive income for the quarter ending June 30, 2024 was $-7.816B, a 3.53% decline year-over-year.

  • Pfizer comprehensive income for 2023 was $-7.961B, a 4.13% decline from 2022.
  • Pfizer comprehensive income for 2022 was $-8.304B, a 40.82% increase from 2021.
  • Pfizer comprehensive income for 2021 was $-5.897B, a 11.05% increase from 2020.

Pfizer Comprehensive Income 2010-2024 | PFE

  • Pfizer comprehensive income for 2023 was $-7.961B, a 4.13% decline from 2022.
  • Pfizer comprehensive income for 2022 was $-8.304B, a 40.82% increase from 2021.
  • Pfizer comprehensive income for 2021 was $-5.897B, a 11.05% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Sanofi (SNY)$133B
Innoviva (INVA)$953M